Source: LevelJump Healthcare Corp.
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Leveljump Healthcare (JUMP) has appointed three new directors and one new advisory board member
  • Gary Prihar, Richard Jagodnik, and Jacki Glazer will join Leveljump’s board of Directors
  • Leveljump has also appointed Dr. Jonathan Chung to its advisory board
  • The new board members will lead Leveljump as the company looks to make more strategic acquisitions in the coming months
  • Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology
  • Shares in Leveljump Healthcare are steady, trading at $0.15 per share

Leveljump Healthcare (JUMP) has appointed three new directors and one new advisory board member.

Gary Prihar, Richard Jagodnik, and Jacki Glazer will join the Leveljump team on its board of directors as the company progresses towards its goal of organic growth.

Mr. Prihar will bring his extensive health care clinic experience to spearhead Leveljump’s advanced training in outreach, telemedicine, and expansive growth strategies. He has served as president and co-founder of Move Health & Wellness, president, CFO, and co-founder of Viva Care Medical and Telehealth, and senior consultant and board member of Lyte Medical.

Mr. Jagodnik has had over 10 years of audit experience, followed by 20 years of being a controller and CFO for private corporations. He is an alumnus of the John Molson School of Business at Concordia University with a major in accounting and received his CA designation in 1994.

Ms. Glazer has over 20 years of experience as a business partner and advisor on leadership teams in a number of industries. Her roles in public and private companies have allowed her to lead financing and operations through periods of acquisition-led growth.

The three new directors will lead Leveljump as the company looks to make more strategic acquisitions in the coming months. They join the team as Mr. Jeff Stevens and Ms. Sandy Hall announced their resignations from the company’s board of directors.

In addition to the new directors, Leveljump has appointed Dr. Jonathan Chung to its advisory board.

Dr. Chung is a radiologist with expertise in interventional radiology and teleradiology. He has extensive experience working in hospitals, acting as chief resident, and also serves as a lead radiologist for CTS.

Dr. Chung can assist Leveljump with radiology workflow, medical protocols, radiology practice expansion and other medical areas as needed.

“We are very pleased to welcome a number of new faces with extensive business, accounting and healthcare experience to our board of directors and our advisory board,” said Mitch Geisler, Leveljump CEO. “We feel that the new board, through its diversity and depth of business experience will be able to guide the company through its next phase of growth.”

Leveljump Healthcare is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology.

Shares in Leveljump Healthcare are steady, trading at $0.15 per share as of 3:45 pm EST.

More From The Market Herald

" Satellos Bioscience (TSXV:MSCL) changing the way we think of degenerative muscle diseases

Satellos Bioscience (MSCL) has filed a patent application with the US Patent and Trademark Office.

" NervGen Pharma (TSXV:NGEN) announces US$15M private placement

NervGen Pharma (NGEN) has announced a non-brokered private placement for gross proceeds of US$15,225,000.

" Feeding our plant-based future

One of the fastest-growing segments today is the plant-based industry, as the push towards cleaner lifestyles, eating habits, and sustainable living choices fuel

" Salona Global (TSXV:SGMD) expands product distribution

Salona Global (SGMD) has signed an agreement to distribute the Hyperice suite of products and delivered 600 units of its newly launched Mio-Guard.